One Concerned Son

This concerned son is PGA champion Jason Day. When his mother, Dening, was diagnosed with stage IV non-small cell lung cancer, they learned that adding biomarker testing to the equation could equal an even more complete diagnosis.

It cut me deep.

Nothing tests you like finding out your mom has lung cancer.”

Watch how adding biomarker testing helped Jason Day and his mom get her complete diagnosis and determine her best shot at treating her stage IV non-small cell lung cancer.

Jason’s concern for his mother overpowered everything.

Jason's #1 priority was to focus solely on her care.

After talking to doctors, Jason and his mom learned how important it is to get a complete diagnosis with biomarker testing. For Dening, it allowed her doctors to better understand her specific type of cancer and choose a therapy that's proven to treat it.

Biomarker testing

Biomarker Testing

Certain biomarkers can be the “drivers” that cause stage IV non-small cell lung cancer to grow and spread. But you won’t learn about all of your cancer’s biomarkers from an initial diagnosis. Having biomarker testing helps give you and your doctor a more complete diagnosis for your specific type of cancer.

Biomarker testing could lead to a better understanding of what may cause your stage IV non-small cell lung cancer to grow and spread. And it could help you and your doctor decide the best treatments to stop it.
Two ways to test for biomarkers in stage IV non-small cell lung cancer: a tissue biopsy removes tissue from a tumor and can be done as a separate procedure or as part of a surgical resection; a blood test can also be used (called a liquid biopsy). Talk to your doctor about which option is right for you.
Biomarker testing helps your doctor determine appropriate treatment options

Best Shot for Mom

For Jason’s mother, adding biomarker testing helped identify the right treatment for her.

If your stage IV non-small cell lung cancer tests positive for a specific biomarker, you and your doctor may discuss therapies that can target it. These “targeted therapies” target certain biomarkers that drive certain types of lung cancer to grow and spread. As a result, targeted therapies may give you more time without cancer growing or spreading.

Biomarker testing

helped us understand my mum’s type of cancer and her next steps.”

Talk with your doctor about adding biomarker testing for your complete diagnosis.

For more support and resources, meet the community at

The information on this Web site is provided by AstraZeneca for educational purposes only and should not take the place of talking with your doctor or health care professional. It should not be used for diagnosing or treating a health problem or disease. If you have any questions about your medical condition, talk to your doctor or pharmacist.

This information is intended for US consumers only.